Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Effectiveness of a clinical practice intervention in early rheumatoid arthritis.

Descalzo MÁ, Carbonell J, González-Álvaro I, Sanmartí R, Balsa A, Hernandez-Barrera V, Román-Ivorra JA, Ivorra-Cortés J, Lisbona P, Alperi M, Jiménez-Garcia R, Carmona L; SERAP and PROAR Study Groups.

Arthritis Care Res (Hoboken). 2012 Mar;64(3):321-30. doi: 10.1002/acr.20682.

2.

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.

Silverman SL, Chines AA, Kendler DL, Kung AW, Teglbjærg CS, Felsenberg D, Mairon N, Constantine GD, Adachi JD; Bazedoxifene Study Group.

Osteoporos Int. 2012 Jan;23(1):351-63. doi: 10.1007/s00198-011-1691-1. Epub 2011 Jul 21.

PMID:
21779819
3.

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide.

Blumsohn A, Marin F, Nickelsen T, Brixen K, Sigurdsson G, González de la Vera J, Boonen S, Liu-Léage S, Barker C, Eastell R; EUROFORS Study Group.

Osteoporos Int. 2011 Jun;22(6):1935-46. doi: 10.1007/s00198-010-1379-y. Epub 2010 Oct 12.

4.

Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS.

Lyritis G, Marin F, Barker C, Pfeifer M, Farrerons J, Brixen K, del Pino J, Keen R, Nickelsen TN; EUROFORS Study Group.

Curr Med Res Opin. 2010 Aug;26(8):1799-807. doi: 10.1185/03007995.2010.488516.

PMID:
20482322
5.

Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain.

Mas AJ, Carmona L, Valverde M, Ribas B; EPISER Study Group.

Clin Exp Rheumatol. 2008 Jul-Aug;26(4):519-26.

PMID:
18799079
6.

Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy.

van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Martin Mola E, Pedersen R, Robertson D, Chang D, Koenig A, Freundlich B; Etanercept Study Investigators.

Ann Rheum Dis. 2009 Jul;68(7):1113-8. doi: 10.1136/ard.2008.094375. Epub 2008 Aug 21.

7.

Prevalence, risk factors, and impact of knee pain suggesting osteoarthritis in Spain.

Fernandez-Lopez JC, Laffon A, Blanco FJ, Carmona L; EPISER Study Group.

Clin Exp Rheumatol. 2008 Mar-Apr;26(2):324-32.

PMID:
18565256
8.

The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry.

Carbonell J, Cobo T, Balsa A, Descalzo MA, Carmona L; SERAP Study Group.

Rheumatology (Oxford). 2008 Jul;47(7):1088-92. doi: 10.1093/rheumatology/ken205. Epub 2008 May 29.

PMID:
18511475
9.

Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment.

Obermayer-Pietsch BM, Marin F, McCloskey EV, Hadji P, Farrerons J, Boonen S, Audran M, Barker C, Anastasilakis AD, Fraser WD, Nickelsen T; EUROFORS Investigators.

J Bone Miner Res. 2008 Oct;23(10):1591-600. doi: 10.1359/jbmr.080506.

10.

Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease.

Loza E, Jover JA, Rodriguez L, Carmona L; EPISER Study Group.

Semin Arthritis Rheum. 2009 Feb;38(4):312-9. doi: 10.1016/j.semarthrit.2008.01.004. Epub 2008 Mar 12.

PMID:
18336872
11.

Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis.

Boonen S, Marin F, Obermayer-Pietsch B, Simões ME, Barker C, Glass EV, Hadji P, Lyritis G, Oertel H, Nickelsen T, McCloskey EV; EUROFORS Investigators.

J Clin Endocrinol Metab. 2008 Mar;93(3):852-60. Epub 2007 Dec 26.

PMID:
18160462
12.

Baseline serum RANKL levels may serve to predict remission in rheumatoid arthritis patients treated with TNF antagonists.

González-Alvaro I, Ortiz AM, Tomero EG, Balsa A, Orte J, Laffon A, García-Vicuña R.

Ann Rheum Dis. 2007 Dec;66(12):1675-8. Epub 2007 Jul 31.

13.

Reproducibility of metacarpophalangeal bone mass measurements obtained by dual-energy X-ray absorptiometry in healthy volunteers and patients with early arthritis.

Castañeda S, González-Alvaro I, Rodríguez-Salvanés F, Quintana ML, Laffon A, García-Vadillo JA.

J Clin Densitom. 2007 Jul-Sep;10(3):298-305. Epub 2007 Jun 18.

PMID:
17574466
14.

Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator.

Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M, Blanco FJ, Benito P, Martín-Mola E, Paulino J, Marenco JL, Porto A, Laffon A, Araújo D, Figueroa M, Branco J.

Arthritis Rheum. 2007 Feb;56(2):555-67.

15.

Ultrasonographic assessment of inflammatory activity in rheumatoid arthritis: comparison of extended versus reduced joint evaluation.

Naredo E, Gamero F, Bonilla G, Uson J, Carmona L, Laffon A.

Clin Exp Rheumatol. 2005 Nov-Dec;23(6):881-4.

PMID:
16396709
16.

Reumatología clínica. Nuestra revista.

Laffón A, Vázquez-Mellado J.

Reumatol Clin. 2005 Jun;1(1):1. doi: 10.1016/S1699-258X(05)72704-2. Epub 2008 Dec 20. Spanish. No abstract available.

17.

Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.

Fernández-Nebro A, Tomero E, Ortiz-Santamaría V, Castro MC, Olivé A, de Haro M, Portales RG, González-Mari MV, Laffón A, García-Vicuña R.

Am J Med. 2005 May;118(5):552-6. No abstract available. Erratum in: Am J Med. 2006 Feb;119(2):191. Garcia-Vicuna, Rosa [corrected to Portales, Rosa García ].

PMID:
15866260
18.
19.

Increased serum levels of interleukin-15 in rheumatoid arthritis with long- term disease.

Gonzalez-Alvaro I, Ortiz AM, Garcia-Vicuña R, Balsa A, Pascual-Salcedo D, Laffon A.

Clin Exp Rheumatol. 2003 Sep-Oct;21(5):639-42.

PMID:
14611115
20.

CD69 expression on lymphocytes and interleukin-15 levels in synovial fluids from different inflammatory arthropathies.

Ortiz AM, Laffon A, Gonzalez-Alvaro I.

Rheumatol Int. 2002 Mar;21(5):182-8.

PMID:
11958434

Supplemental Content

Loading ...
Support Center